SITAVAC 3D TAB

SITAVAC 3D Tablet is a powerful triple-combination antidiabetic medicine containing Sitagliptin, Metformin, and Dapagliflozin. It is prescribed to patients with Type 2 Diabetes Mellitus (T2DM) to achieve better blood sugar control when lifestyle changes and single/dual therapy are not enough.

This unique combination works through three mechanisms – improving insulin sensitivity, reducing glucose production in the liver, and enhancing glucose excretion through urine – thereby providing comprehensive diabetes management.

Key Benefits:

• Helps lower high blood sugar levels in Type 2 Diabetes

• Reduces the risk of diabetes-related complications (nerve damage, kidney problems, heart disease)

• Improves insulin response and glucose utilization

• Supports weight management in diabetic patients

• Provides synergistic action of three proven antidiabetic agents